Breast Carcinoma Diagnosis, Treatment, and Prognosis before and after the Introduction of Mass Mammographic Screening

Cancer

Volumn 100, Issue 7, 2004, Pages 1337-1344

  Ernst, Miranda F ^a,d   Voogd, Adri C ^b,e   Coebergh, Jan Willem W ^b,c   Roukema, Jan A ^a  

^a CPRLab   (Netherlands)

^b The Netherlands   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast carcinoma; Breast conserving surgery; Mammographic screening; Prognosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PRACTICE GUIDELINES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 1642311321     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20139     Document Type: Article

References (33)

1. Game JP, Aspegren K, Balldin G, Ranstam J. Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmo, Sweden, 1961-1992. Cancer. 1997;79:69-74.
2. Nab HW, Voogd AC, Crommelin MA, Kluck HM, van der Heijden LH, Coebergh JW. Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer. 1993;29:1557-1559.
3. Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival and mortality rates. J Natl Cancer Inst. 1996;88:1571-1579.
4. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000;321:665-669.
5. Levi F, Lucchini F, Negri E, La Vecchia C. The fall in breast cancer mortality in Europe. Eur J Cancer. 2001;37:1409-1412.
6. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer. 1998;82:1197-1207.
7. Moody-Ayers SY, Wells CK, Feinstein AR. "Benign" tumors and "early detection" in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med. 2000;160:1109-1115.
8. Sant M, Capocaccia R, Verdecchia A, et al. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. Int J Cancer. 1998;77:679-683.
9. Hermanek P, Sobin LH, editors. UICC TNM classification of malignant tumours. Berlin: Springer-Verlag, 1987.
10. Van der Maas PJ, de Koning HJ, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989;43:1055-1060.
11. Ernst MF, Roukema JA, Coebergh JW, et al. Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res Treat. 2002;76:19-25.
12. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ. 1995;311:1391-1395.
13. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353:1903-1908.
14. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
15. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast cancer mortality: a systematic review. Lancet. 2003;361:1411-1417.
16. Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age: new results from the Swedish Two-County Trial. Cancer. 1995;75:2507-2517.
17. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94:167-173.
18. Gotzsche PC. Mortality reduction by breast cancer screening. Lancet. 2003;362:246.
19. Vainio H, Bianchini F, editors. IARC handbooks of cancer prevention. Volume 7: breast cancer screening. Lyon: IARC Press, 2002.
20. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer. 1999;81:912-917.
21. Gilliland FD, Joste N, Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst. 2000;92:743-749.
22. Porter PL, El-Bastwissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999;91:2020-2028.
23. Cowan WK, Angus B, Gray JC, Lunt LG, al-Tamimi SR. A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol. 2000;53:140-146.
24. Schroen AA, Wobbes T, van der Sluis RF. Interval carcinomas of the breast: a group with intermediate outcome. J Surg Oncol. 1996;63:141-144.
25. Brekelmans CT, Peeters PH, Deurenberg JJ, Collette HJ. Survival in interval breast cancer in the DOM screening programme. Eur J Cancer. 1995;31A:1830-1835.
26. Groenendijk RP, Bult P, Noppen CM, Boetes C, Ruers TJ, Wobbes T. Mitotic activity index in interval breast cancers. Eur J Surg Oncol. 2003;29:29-31.
27. Ernst MF, Voogd AC, Coebergh JW, Repelaer van Driel OJ, Roukema JA. Little effect of the introduction of mammographic screening on the trend in breast-conserving surgery: a population-based study in South-East Netherlands. Eur J Cancer. 2001;37:2435-2440.
28. Nattinger AB, Hoffmann RG, Kneusel RT, Shapira MM. Relation between appropriateness of primary therapy for early stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148-1153.
29. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in Stage I and II breast carcinoma. J Clin Oncol. 2001;19:254-262.
30. Solin LJ, Legorretta A, Schultz DJ, Zatz S, Goodman RL. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. Arch Intern Med. 1994;154:745-752.
31. Crawford MD, Biankin AV, Rickard MT, et al. The operative management of screen-detected breast cancers. Aust N Z J Surg. 2000;70:168-173.
32. Paci E, Duffy SW, Giorgi D, et al. Are breast cancer screening programmes increasing rates of mastectomy? Observational study. BMJ. 2002;325:418.
33. Martelli G, DePalo G, Rossi N, et al. Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen. Br J Cancer. 1995;72:1251-1255.